FDA nanotechnology task force
This article was originally published in The Gray Sheet
Executive Summary
Newly formed task force will assess the agency's readiness to handle a swelling wave of medical nanotechnology, wherein the control of matter at the nano level - one thousand- to one hundred thousand-times smaller than the thickness of a sheet of paper - enables novel applications, according to an Aug. 9 release (1"The Gray Sheet" April 24, 2006, p. 12). The task force will seek to identify gaps in policy and/or institutional knowledge and craft regulatory approaches that encourage the continued development of devices that incorporate nanomaterials. A public meeting is scheduled for Oct. 10 to explore such topics as the biological interactions unique to nanotechnology that may lead to either beneficial or adverse health effects...